Latest News for: revera
Edit
Milestone Pharmaceuticals Announces First European Study Participant Enrolled in ReVeRA-301 Phase 3 Clinical Trial
Nasdaq Globe Newswire 09 Oct 2026
Dutch Cardiovascular Investigator Network (WCN) Leads ...
Edit
Pinsent Masons advises Revera Energy on 400MW / 800MWh Hunterston BESS Project (Pinsent Masons LLP)
Public Technologies 01 Oct 2026
Multinational law firm Pinsent Masons has advised Revera Energy (Revera), a global independent energy platform backed by global investment firm Carlyle, on all construction and optimisation aspects of the 400MW / 800MWh Hunterston BESS Project.
Edit
Milestone Pharmaceuticals Enrolls First Canadian Study Participant in ReVeRA-301 Phase 3 Pivotal Trial Evaluating Etripamil ...
Nasdaq Globe Newswire 25 Sep 2026
Montreal Heart Institute Joins Multinational Study Evaluating a Self-Administered 70 mg Repeat-Dose Regimen of Etripamil. Montreal Heart Institute Joins Multinational Study Evaluating a Self-Administered 70 mg Repeat-Dose Regimen of Etripamil ... .
- 1